Embryonic stem cells: a novel tool for the study of antiangiogenesis and tumor-induced angiogenesis

Area of Science:

• Biomedical research
• Cell biology
• Cancer therapy

Background:

• Antiangiogenesis research targets diseases like cancer, polyarthritis, and diabetic retinopathy.
• Current in vitro and in vivo angiogenesis assays lack the complexity of a natural tissue microenvironment.
• Novel assays are needed to replicate oxygen/nutrient gradients and intracellular conditions found in vivo.

Purpose of the Study:

• To review embryonic stem cells as a novel tool for antiangiogenesis research.
• To outline the use of confrontation cultures for studying tumor-induced angiogenesis.
• To highlight the need for advanced in vitro models mimicking natural tissue conditions.

Main Methods:

• Utilizing mouse and human embryonic stem cells to form three-dimensional tissues with functional capillaries.
• Employing confrontation cultures of stem cells with multicellular tumor spheroids.
• Monitoring the invasion of host-derived endothelial cells into tumor tissue.

Main Results:

• Embryonic stem cell-derived tissues provide a functional in vitro model for antiangiogenesis studies.
• Confrontation cultures enable monitoring of tumor-induced angiogenesis, specifically endothelial cell invasion.
• This model system effectively simulates key aspects of the natural tissue microenvironment.

Conclusions:

• Embryonic stem cells represent a promising in vitro model for antiangiogenesis research.
• Confrontation cultures with stem cells are valuable for studying tumor-induced angiogenesis.
• This approach advances the development of anti-cancer therapies by better understanding angiogenesis.